适应性试验设计的置信区间II:案例研究与实用指南
本文是适应性试验置信区间两部分系列的第二部分,基于两阶段组序贯试验的扩展案例研究和全面模拟研究,展示不同置信区间方法性质差异显著,并为研究人员提出适应性设计后置信区间选择与报告的指南。
要点
- 适应性试验中传统置信区间易出现覆盖不足及与最终假设检验决策不一致的问题。
- 基于两阶段组序贯试验的模拟研究显示不同置信区间方法性质差异显著。
- 作者提出适应性设计后置信区间选择与报告的指南。
核心结论
- 适应性试验中不同置信区间方法性质差异显著,作者据此提出置信区间选择与报告的指南。
研究设计与样本
- 本文为两部分系列文章的第二部分,基于两阶段组序贯试验开展扩展案例研究,并对所提出的置信区间进行全面的模拟研究。
主要发现
- 模拟研究显示,适应性试验中所用的置信区间可以具有显著不同的性质。
临床怎么用
- 近期关于适应性设计的监管指南指出,对适应性临床试验期间及之后构建的置信区间需谨慎解读。
- 作者提出了一套关于适应性设计后置信区间选择与报告的指南。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
In adaptive clinical trials, the conventional confidence interval (CI) for a treatment effect is prone to undesirable properties such as undercoverage and potential inconsistency with the final hypothesis testing decision. Accordingly, as is stated in recent regulatory guidance on adaptive designs, there is the need for caution in the interpretation of CIs constructed during and after an adaptive clinical trial. However, it may be unclear which of the available CIs in the literature are preferable. This paper is the second in a two-part series that explores CIs for adaptive trials. Part I provided a methodological review of approaches to construct CIs for adaptive designs. In this paper (Part II), we present an extended case study based around a two-stage group sequential trial, including a comprehensive simulation study of the proposed CIs for this setting. This facilitates an expanded description of considerations around what makes for an effective CI procedure following an adaptive trial. We show that the CIs can have notably different properties. Finally, we propose a set of guidelines for researchers around the choice of CIs and the reporting of CIs following an adaptive design.
引用
- Robertson DS, Burnett T, Choodari-Oskooei B, et al. Confidence Intervals for Adaptive Trial Designs II: Case Study and Practical Guidance. Stat Med. 2025. PMID: 40781756. doi:10.1002/sim.70202
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。